Drug Type Cytokines |
Synonyms CPT (Hiteck Biological), Human recombinant Apo2L/TRAIL, 重组变构人肿瘤坏死因子相关凋亡诱导配体 (海特生物) + [1] |
Target |
Mechanism DR4 agonists(Tumor necrosis factor receptor superfamily member 10A agonists), DR5 agonists(Tumor necrosis factor receptor superfamily member 10B agonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhaseApproved |
First Approval Date CN (01 Nov 2023), |
Regulation- |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Multiple Myeloma | CN | 01 Nov 2023 |
Phase 3 | Multiple Myeloma Third line | 417 | azhzhtuuvq(iocygechvl) = ltpntkyazi ubymocjbsa (adcdbrjtkf ) View more | Positive | 15 Jun 2020 | ||
azhzhtuuvq(iocygechvl) = vfxfsiojvc ubymocjbsa (adcdbrjtkf ) View more | |||||||
Phase 2 | 27 | xnphilrxcs(cetnghdzio) = bkzkcoviie ezuwpflsqv (vzeiyvrppw ) View more | Positive | 08 Sep 2016 |